[395] DOG1: Utility in Diagnosing Gastrointestinal Stromal Tumors on Fine Needle Aspiration.
Richard Kraus, Cynthia Cohen, Momin T Siddiqui. Emory University Hospital, Atlanta, GA
Background: Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the GI tract, and the majority contain KIT or PDGFRA activating mutations. Fine needle aspiration biopsy (FNAB) is a valuable tool in the diagnosis of GIST, and may allow for pre-operative therapy with tyrosine kinase inhibitors (TKI). Because of the morphologic diversity of these tumors, routine diagnosis of GIST often relies on C-Kit immunohistochemical staining in addition to morphologic findings. However, up to 15% of GISTs are C-Kit negative. Antibodies with increased sensitivity and specificity for detection of C-Kit negative GIST cases could be of value, especially since some of these cases may also benefit from TKI therapy.
Design: Immunohistochemical staining for DOG-1, C-kit (CD117), and protein kinase C theta (PKCθ) was performed on FNA cell block preparations representing 18 GISTs, 17 leiomyosarcomas, 16 melanomas, 16 schwannomas and 11 adenoid cystic carcinomas (ACC).
Results:
| GIST | Leiomyosarcoma | Melanoma | Schwannoma | ACC | |
| DOG-1 | 18/18 (100%) | 0/17 (0%) | 0/16 (0%) | 0/16 (0%) | 0/11 (0%) |
| C-Kit | 13/18 (72.2%) | 1/17 (5.9%) | 4/16 (25%) | 0/16 (0%) | 10/11 (90.9%) |
| PKCθ | 6/18 (33.3%) | 1/17 (5.9%) | 5/16 (31.6%) | 0/15 (0%) | 1/10 (10%) |